Princeton Univ. to Offer Students Unapproved Meningitis Vaccine

The vaccine will be administered in two doses.

   

Princeton University is planning to offer students a meningitis vaccine that hasn’t yet been approved by the U.S. Food and Drug Administration (FDA).

Princeton, which is currently facing a meningitis B outbreak, plans to offer the vaccine to students free of charge. The vaccine has already received approval from the European Union and has been also approved for use in Australasia. The vaccine will be distributed in two separate doses: one will be administered in December and the other in February. The U.S. Centers for Disease Control got approval from the FDA to import the vaccine due to the outbreak, reports Businessweek.

Meningitis B is a strain that is not covered by the normal protocols and vaccinations in the United States. Meningitis B is spread through saliva and can result in symptoms including: fever, headache, vomiting, a sore neck, and sensitivity to light. It also causes inflammation around the brain and spinal cord, Businessweek notes.

“People are worried, but not really worried enough,”  Philip Powers, a freshman at Princeton University, told USA Today. “People are definitely thinking about it and concerned about it but people are still sharing drinks and stuff.”


Article printed from InvestorPlace Media, http://investorplace.com/2013/11/princeton-univ-offer-students-unapproved-meningitis-vaccine/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.